Case Reports in Otolaryngology

Case Reports in Otolaryngology / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 3939685 | 4 pages | https://doi.org/10.1155/2016/3939685

Facial Nerve Schwannoma of Parotid Gland: Difficulties in Diagnosis and Management

Academic Editor: Seckin Ulualp
Received19 Nov 2015
Accepted04 Jan 2016
Published20 Jan 2016

Abstract

Facial nerve schwannomas (FNS) are encapsulated benign tumors arising from Schwann cells of seventh cranial nerve. Most of the facial nerve schwannomas are localized in intratemporal region; only 9% of cases involve a portion of the extratemporal segment. Preoperative diagnosis is often unclear; diagnosis is often made intraoperatively. Management of intraparotid FNS is troublesome because of the facial nerve paralysis. In this report we presented a case of intraparotid schwannoma in a 55-year-old male patient complaining of a painless mass without peripheral facial nerve palsy in left parotid gland. Clinical features, preoperative and intraoperative diagnosis, and difficulties during management are discussed with the review of the literature.

1. Introduction

Schwannomas (neurilemmomas) are rare benign, slow growing, encapsulated tumors that are arising from Schwann cells of myelinated peripheric or cranial nerves [1]. Twenty-five percent of all schwannomas originate from the neural structures of head and neck region. Facial nerve schwannomas (FNS) can arise from Schwann cells of seventh cranial nerve, at any part from the glial-Schwann cell junction at the cerebellopontine angle to the terminal branches of the medial face. Schwannomas of the facial nerve are uncommon. Most of the facial nerve schwannomas are localized in intratemporal region; only 9% of cases involve a portion of the extratemporal segment [1, 2].

Intraparotid FNS most commonly presents as a painless, slow growing parotid mass with normal facial nerve function [3]. Generally it is difficult to diagnose preoperatively. In this report we presented a case of intraparotid schwannoma in the left parotid region. Clinical features, preoperative and intraoperative diagnosis, and difficulties during management are discussed with the review of the literature.

2. Case Report

A 55-year-old male patient complaining of a painless mass in the left preauricular area that had been present for 3 months was admitted to our clinic. There was no other symptom and his general physical examinations were completely normal. Physical examination showed a  mm mass in left parotid gland that is partially mobile and painless and covered with normal skin. The facial nerve functions were normal on clinical evaluation. Fine-needle aspiration cytology (FNAC) result was nondiagnostic and complete blood count was normal.

In magnetic resonance imaging (MRI) a homogeneous  mm lesion was detected in superficial and deep lobes of left parotid gland spreading to anterior of masseter muscle which is hypointense in T1A sections and hyperintense in T2A sections and with intense contrast enhancement (Figures 1(a) and 1(b)).

A parotidectomy was planned for the patient. During the operation firstly the main trunk of facial nerve was identified. The main part of the tumor was a  mm reddish, bright lesion with a thin capsule around the temporofacial branch of facial nerve anterosuperior to main trunk. The lesion was encircling the temporofacial branch of the facial nerve and advancing forward through the peripheral branches. At this point we could not follow the nerve, so we referred to frozen section. The result was reported as “mesenchymal lesion.” When we stimulated the lesion with the nerve stimulator we got an answer from the muscles that were innervated by that branch and because of the frozen section result we thought that the lesion might be a tumor of the nerve itself. In this occasion we cut the temporofacial branch of the nerve from the main trunk and excised the tumor totally with branches (zygomatic, temporal, and buccal branches) surrounding the mass medially (Figures 2(a), 2(b), and 2(c)). A weakness was detected in left eyelid postoperatively. The patient was able to close his eye with effort so no additional intervention was considered afterwards. The weak conservation of eyelid function despite the sacrificing of temporofacial branch could be explained by the compensation from collateral peripheral branches located in front of the resected tumor.

The histopathologic result was reported as “schwannoma.” The cells that build the tumor were fusiform nucleated spindle cells and had eosinophilic cytoplasms with ill-defined boundaries. In these cells there was palisade forming hypercellular areas and wavy structure of the fibers in the stroma in some places. There was no necrosis, mitosis, or atypia. The neoplastic cells were vimentin and S-100 positive immunohistochemically (Figures 3(a) and 3(b)).

3. Discussion

Schwannomas were first reported by Virchow in 1908 and arise from the neural sheath of the peripheral sensory, motor, sympathetic, and cranial nerves [3, 4]. Schwannomas are encapsulated, soft and white, yellow, or pink tumors. They occasionally feature areas of calcification and/or cystic degeneration. Their capsule is continuous with the epineurium, the most external nerve sheath [5]. Microscopically the diagnosis is confirmed by histopathologic evaluation. Histologically, two types of tissues are seen: the Antoni A area is characterized by the presence of elongated and spindle-shaped Schwann’s cells, and their nuclei are aligned in a palisading pattern (Verocay bodies). The hypo cellular Antoni B area has a varying degree of cell pleomorphism; irregular cell types are scattered in loose connective tissue, and there is no definable palisading of tumor cell nuclei. Both Antoni areas are usually found in the same tumor, but their respective proportions vary. Nerve fibers are not part of the tumor because the mass arises from Schwann’s sheath and pushes the nerve axons aside [5, 6]. Immunostaining for S-100 is required to establish the neural origin of the tumor and smooth muscle actin (SMA) to rule out a leiomyoma [7].

FNS are uncommon; approximately 25% and 40% of all schwannomas have occurred in the head and neck region. These tumors are most common tumors of facial nerve and can be either benign or malignant. The majority of FNS are intratemporal, with 9% of cases arising from the intraparotid portion [8]. Caughey et al. had conducted a retrospective study over 38-year period, focusing on facial nerve schwannoma involving parotid gland. Out of a total of 3722 patients with schwannomas reviewed, only 29 were related to facial nerve. From this small group, only eight involved the parotid segment of the facial nerve [9].

Intraparotid FNS are solitary, painless, slow growing masses mimicking the tumors of the parotid gland and have a different clinical presentation. Although tumor arises from the nerve itself, the function of the facial nerve is generally unaffected [9, 10]. It is interfered with malignant parotid tumors if there are facial paralysis and pain. The incidence of intraparotid facial nerve palsy is approximately %20-27 [11]. The ability of the parotid gland to accommodate tumor expansion well and the propensity of tumor to grow eccentrically and push nerve fibers away account for the low rate of facial palsy in intraparotid FNS [12].

It is difficult to distinguish the intraparotid FNS from other parotid tumors preoperatively. But it is also essential to design the treatment. Computed tomography (CT) scan usually shows a smooth, sharply circumscribed lesion in the parotid. It is not a preferred imaging modality for FNS, but it may reveal osseous changes [13]. Sonographically, neurogenous tumors present as spindle-shaped masses with cystic areas [9]. MRI is the most appropriate imaging technic in detecting facial nerve schwannoma along the course of the facial nerve. It shows a mass with signal intensity isointense to muscle on T1 and hyperintense to muscle on T2 sequence, respectively [13]. The target sign (central low and peripheral higher signal intensity on T2 weighted images) is suggestive of a neurogenous tumor such as benign facial nerve schwannoma or malignant nerve sheath neoplasm [14]. FNAC is generally unsuccessful in diagnosis of intraparotid nerve schwannomas and results are inconclusive as in our case [7, 15, 16]. FNAC may reveal spindle-shaped cells with ill-defined cytoplasm, arranged in clusters (Verocay bodies) [17].

Treatment of intraparotid FNS is surgical excision. Because preoperative diagnosis is impossible, much responsibility falls to the surgeon during the operation. Because in almost all cases no facial nerve palsy is detected preoperatively; even during surgery, it can be difficult to determine whether the tumor originated from the parotid gland or the facial nerve; half of the tumors originate from the main trunk of the facial nerve and that is why it is impossible to find main trunk. There are strong adhesions between the tumor and the nerve and so in such cases surgery becomes quite difficult. During the operation if it is seen that tumor is adherent to the nerve and it is impossible to dissect them, intraoperative frozen section examination is recommended for both diagnosis and excluding malignancy [10, 18, 19]. In our case we made a frozen section to distinguish if the tumor is originated from parotid tissue or the facial nerve itself. The result was reported as “mesenchymal tumor.” Because the tumor could not be separated from the nerve we had to sacrifice the temporofacial branch to resect the tumor. Benign FNS grow slowly and resection is not always indicated [20]. Several authors have reported the occurrence of facial palsy when an intraparotid facial nerve tumor was simply biopsied or carefully resected with apparent preservation of the facial nerve [21, 22], but other authors advocate its removal if it can be dissected easily off the nerve [23, 24].

Marchioni et al. suggested a classification of intraparotid FNS according to its position in the facial nerve pathway. In this classification, there are 4 types of intraparotid FNS. Type A tumors can be resected without sacrificing the facial nerve. Type B tumors can be resected with partial sacrifice peripheral branches of facial nerve or their distal divisions. Type C tumors require sacrificing the main trunk of the facial nerve for their resection, while type D tumors require sacrificing the trunk and its main divisions to be resected [24]. Our presented case was considered as type B.

As a result FNS are quite rare tumors and the preoperative diagnostic tests usually provide no valuable information. Frozen section examination that has been performed intraoperatively is recommended for both diagnosis and exclusion of malignancy. During management it seems important to behave conservatively because tumor rarely affects the facial nerve function and grows very slowly. Complete excision leads to complete cure.

Ethical Approval

All authors assert that all procedures used met the appropriate ethical standards.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. H. K. Shah, C. Kantharia, and A. S. Shenoy, “Intraparotid facial nerve schwannoma,” Journal of Postgraduate Medicine, vol. 43, no. 1, pp. 14–15, 1997. View at: Google Scholar
  2. B. C. Gross, M. L. Carlson, E. J. Moore, C. L. Driscoll, and K. D. Olsen, “The intraparotid facial nerve schwannoma: a diagnostic and management conundrum,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 33, no. 5, pp. 497–504, 2012. View at: Publisher Site | Google Scholar
  3. D. O. Gore, R. Rankow, and J. M. Hanford, “Parapharyngeal neurilemmoma,” Surgery, Gynecology & Obstetrics, vol. 103, no. 2, pp. 193–201, 1956. View at: Google Scholar
  4. S. C. Parisier, D. R. Edelstein, and M. J. Levenson, “Facial nerve neuromas,” in Otolaryngology, M. M. Paparella, D. A. Shumrick, J. L. Gluckman, and W. L. Meyerhoff, Eds., pp. 1465–1466, W.B. Saunders Company, Philadelphia, Pa, USA, 1991. View at: Google Scholar
  5. M. Kyriakos, “Neurogenous tumors,” in Comprehensive Management of Head and Neck Tumors, S. E. Thawley and W. R. Panje, Eds., pp. 1253–1261, W. B. Saunders, Philadelphia, Pa, USA, 1987. View at: Google Scholar
  6. J. R. Johnson, E. N. Myers, and H. D. Curtin, “Tumors of the parapharyngeal space,” in Cancer of the Head and Neck, E. N. Myers and J. Y. Suen, Eds., pp. 669–690, Churchill Livingstone, New York, NY, USA, 1989. View at: Google Scholar
  7. R. K. Verma, R. K. Prasad, S. Bharti, and N. K. Panda, “Intraparotid facial nerve schwannoma involving the deep lobe: a case report,” Egyptian Journal of Ear, Nose, Throat and Allied Sciences, vol. 12, no. 3, pp. 163–166, 2011. View at: Publisher Site | Google Scholar
  8. G. E. J. Forton, L. L. M. Moeneclaey, and F. E. Offeciers, “Facial nerve neuroma. Report of two cases including histological and radiological imaging studies,” European Archives of Oto-Rhino-Laryngology, vol. 251, no. 1, pp. 17–22, 1994. View at: Google Scholar
  9. R. J. Caughey, M. May, and B. M. Schaitkin, “Intraparotid facial nerve schwannoma: diagnosis and management,” Otolaryngology—Head and Neck Surgery, vol. 130, no. 5, pp. 586–592, 2004. View at: Publisher Site | Google Scholar
  10. G. Fyrmpas, I. Konstantinidis, D. Hatzibougias, V. Vital, and J. Constantinidis, “Intraparotid facial nerve schwannoma: management options,” European Archives of Oto-Rhino-Laryngology, vol. 265, no. 6, pp. 699–703, 2008. View at: Publisher Site | Google Scholar
  11. P. Bretlau, H. Melchiors, and A. Krogdahl, “Intraparotid neurilemona,” Acta Oto-Laryngologica, vol. 95, no. 1–4, pp. 382–384, 1983. View at: Publisher Site | Google Scholar
  12. M. Jaehne and J. Ußmüller, “Clinical behaviour and therapy of the extratemporal facial nerve neurinoma,” HNO, vol. 49, no. 4, pp. 264–269, 2001. View at: Publisher Site | Google Scholar
  13. N. Gritzmann, T. Rettenbacher, A. Hollerweger, P. Macheiner, and E. Hübner, “Sonography of the salivary glands,” European Radiology, vol. 13, no. 5, pp. 964–975, 2003. View at: Google Scholar
  14. L. Jäger and M. Reiser, “CT and MR imaging of the normal and pathologic conditions of the facial nerve,” European Journal of Radiology, vol. 40, no. 2, pp. 133–146, 2001. View at: Publisher Site | Google Scholar
  15. J. C. Villatoro, R. Krakowiak-Gómez, M. López, and M. Quer, “Two cases of intraparotid facial nerve schwannoma,” Acta Otorrinolaringológica Española, vol. 62, no. 6, pp. 469–471, 2011. View at: Publisher Site | Google Scholar
  16. M. İrfan, H. Shahid, M. M. Yusri, and R. N. Venkatesh, “Intraparotid facial nerve schwannoma: a case report,” Medical Journal of Malaysia, vol. 66, no. 2, pp. 150–151, 2011. View at: Google Scholar
  17. K. Shimizu, H. Iwai, K. Ikeda, N. Sakaida, and S. Sawada, “Intraparotid facial nerve schwannoma: a report of five cases and an analysis of MR imaging results,” American Journal of Neuroradiology, vol. 26, no. 6, pp. 1328–1330, 2005. View at: Google Scholar
  18. B. N. Kumar, R. M. Walsh, N. M. Walter, A. Tse, and J. T. Little, “Intraparotid facial nerve schwannoma in a child,” Journal of Laryngology and Otology, vol. 110, no. 12, pp. 1169–1170, 1996. View at: Google Scholar
  19. M. A. Alicandri-Ciufelli, D. Marchioni, F. Mattioli, M. Trani, and L. Presutti, “Critical literature review on the management of intraparotid facial nerve schwannoma and proposed decision-making algorithm,” European Archives of Oto-Rhino-Laryngology, vol. 266, no. 4, pp. 475–479, 2009. View at: Publisher Site | Google Scholar
  20. A. P. Avery and P. M. Sprinkle, “Benign intraparotid schwannomas,” Laryngoscope, vol. 82, no. 2, pp. 199–203, 1972. View at: Publisher Site | Google Scholar
  21. K. W. Chong, Y. F. A. Chung, M. L. C. Khoo, D. T. H. Lim, G. S. Hong, and K. C. Soo, “Management of intraparotid facial nerve schwannomas,” Australian and New Zealand Journal of Surgery, vol. 70, no. 10, pp. 732–734, 2000. View at: Publisher Site | Google Scholar
  22. S. I. Angeli and D. E. Brackmann, “Is surgical excision of facial nerve schwannomas always indicated?” Otolaryngology—Head and Neck Surgery, vol. 117, no. 6, pp. S144–S147, 1997. View at: Publisher Site | Google Scholar
  23. A. Kreeft, P. P. A. Schellekens, and H. Leverstein, “Intraparotid facial nerve schwannoma. What to do?” Clinical Otolaryngology, vol. 32, no. 2, pp. 125–129, 2007. View at: Publisher Site | Google Scholar
  24. D. Marchioni, M. A. Ciufelli, and L. Presutti, “Intraparotid facial nerve schwannoma: literature review and classification proposal,” Journal of Laryngology and Otology, vol. 121, no. 8, pp. 707–712, 2007. View at: Publisher Site | Google Scholar

Copyright © 2016 Murat Damar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

6039 Views | 718 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.